The Claim

Long-term use of propylthiouracil in patients with Graves disease is associated with the development of antineutrophil cytoplasmic antibody-associated vasculitis, particularly in women aged 30–60 with comorbid autoimmune conditions such as rheumatoid arthritis.

Source: A grave complication: propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
30score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Correlation
1 study reviewed
In plain English

Long-term use of propylthiouracil in patients with Graves disease is linked to the development of antineutrophil cytoplasmic antibody-associated vasculitis, especially in women aged 30–60 who also have autoimmune conditions like rheumatoid arthritis.

See the scientific wording

Long-term use of propylthiouracil (PTU) in patients with Graves disease may be associated with the development of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, particularly in women aged 30–60 with comorbid autoimmune conditions such as rheumatoid arthritis, as evidenced by a single case in which renal vasculitis developed after five years of therapy and improved following drug discontinuation.

Why this might work

A drug called PTU gets broken down inside white blood cells into reactive chemicals that stick to normal proteins, making them look like foreign invaders. The immune system sees these changed proteins as threats and makes antibodies against them. These antibodies attack the white blood cells themselves, causing them to burst and release harmful substances that damage small blood vessels, especially in the kidneys.

Supported mechanismbased on 1 study

What the research says

1 study

  1. Study: A grave complication: propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis

    A woman with an overactive thyroid took a medicine called PTU for five years, then got a rare kidney disease linked to her immune system. When she stopped taking PTU, she got better. This suggests the medicine might have caused the problem.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.